NAVIDEA BIOPHARM

NAVB AMEX
0.5950
+0.0145
+2.50%
Closed 16:00 07/23 EDT
Open
0.5900
Prev Close
0.5805
High
0.6000
Low
0.5680
Volume
63.90K
Avg Vol (3M)
403.27K
52 Week High
7.39
52 Week Low
0.5400
% Turnover
0.64%
Market Cap
5.99M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers NAVIDEA BIOPHARM NAVB stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Navidea Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. The Company is developing multiple precision-targeted products based on the Manocept platform to help identify the sites and pathways of undetected disease. The Manocept platform is predicated on the ability to specifically target the CD206 mannose receptor expressed on activated macrophages. NAV5001 is an iodine-123 (I-123) radiolabeled single-photon emission computed tomography (SPECT) imaging agent being developed as an aid in the diagnosis of Parkinson's disease (PD) and other movement disorders, with potential use as a diagnostic aid in dementia. NAV4694 is a fluorine-18 (F-18) radiolabeled positron emission tomography (PET) imaging agent being developed as an aid in the diagnosis of patients with signs or symptoms of Alzheimer's disease (AD) and mild cognitive impairment (MCI).
MORE >

Recently

Name
Price
%Change